Keyphrases
Prostate Cancer
100%
Clinical Investigation
100%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
100%
Androgen Receptor Splice Variant
100%
AR-V7
100%
AR Variants
60%
Targeted Therapy
40%
Nuclear Proteins
40%
Epic
40%
AdnaTest
40%
AR Splice Variants
40%
Management Strategy
20%
Cell-based
20%
Effective Treatment
20%
Patient-specific
20%
Circulating Tumor Cells
20%
Taxanes
20%
Treatment Strategy
20%
Systemic Review
20%
Treatment Decisions
20%
Multivariable
20%
Poor Outcome
20%
Resistance Test
20%
Resistance Mechanisms
20%
Liquid Biopsy
20%
Overall Survival
20%
Circulating Tumor DNA (ctDNA)
20%
Early Use
20%
Multiple Mechanisms
20%
Expert Opinion
20%
Clinical Heterogeneity
20%
Progression-free Survival
20%
Targeting Strategies
20%
Protein Assay
20%
Sensitivity to Chemotherapy
20%
Protein Detection
20%
RNA Detection
20%
Broad Resistance
20%
Clinical Behavior
20%
Driver Roles
20%
Medicine and Dentistry
Prostate Cancer
100%
Androgen Receptor
100%
Circulating Tumor Cell
100%
Nuclear Protein
100%
Tumor Marker Rapid Test
100%
Messenger RNA
100%
Liquid Biopsy
50%
Overall Survival
50%
Progression Free Survival
50%
Protein Analysis
50%
Protein Determination
50%
Effective Treatment
50%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
100%
Neoplasm
100%
Nuclear Protein
100%
Messenger RNA
100%
Chemotherapy
50%
Overall Survival
50%
Progression Free Survival
50%
Taxane
50%